Gene · 6599
Papers1,611
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
221 to 240 of 1,611
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
SWI/SNF complex gene variations are associated with a higher tumor mutational burden and a better response to immune checkpoint inhibitor treatment: a pan-cancer analysis of next-generation sequencing data corresponding to 4591 cases. | Cancer Cell Int | 2022 | 36371186 | PubTator, text mining | PubMed |
| Targeting Chromatin-Remodeling Factors in Cancer Cells: Promising Molecules in Cancer Therapy. | Int J Mol Sci | 2022 | 36361605 | PubTator, text mining | PubMed |
| Selective PROTAC-mediated degradation of SMARCA2 is efficacious in SMARCA4 mutant cancers. | Nat Commun | 2022 | 36357397 | PubTator, text mining | PubMed |
| Nuclear Actin Dynamics in Gene Expression, DNA Repair, and Cancer. | Results Probl Cell Differ | 2022 | 36348125 | PubTator, text mining | PubMed |
| Endocrine resistance and breast cancer plasticity are controlled by CoREST. | Nat Struct Mol Biol | 2022 | 36344844 | PubTator, text mining | PubMed |
| The assembly of mammalian SWI/SNF chromatin remodeling complexes is regulated by lysine-methylation dependent proteolysis. | Nat Commun | 2022 | 36335117 | PubTator, text mining | PubMed |
| BRD9-containing non-canonical BAF complex maintains somatic cell transcriptome and acts as a barrier to human reprogramming. | Stem Cell Reports | 2022 | 36332631 | PubTator, text mining | PubMed |
| Current insights into the regulation of programmed cell death by TP53 mutation in cancer. | Front Oncol | 2022 | 36313700 | PubTator, text mining | PubMed |
| ESRP1-regulated isoform switching of LRRFIP2 determines metastasis of gastric cancer. | Nat Commun | 2022 | 36307405 | PubTator, text mining | PubMed |
| Genetics Abnormalities with Clinical Impact in Primary Cutaneous Lymphomas. | Cancers (Basel) | 2022 | 36291756 | PubTator, text mining | PubMed |
| Overexpression of LncRNA SNHG14 as a biomarker of clinicopathological and prognosis value in human cancers: A meta-analysis and bioinformatics analysis. | Front Genet | 2022 | 36276965 | PubTator, text mining | PubMed |
Comparative transcriptome analysis of Citrus macrophylla tree infected with Citrus tristeza virus stem pitting mutants provides new insight into the role of phloem regeneration in stem pitting disease. | Front Plant Sci | 2022 | 36267951 | PubTator, text mining | PubMed |
| Combined inhibition of PARP and EZH2 for cancer treatment: Current status, opportunities, and challenges. | Front Pharmacol | 2022 | 36263120 | PubTator, text mining | PubMed |
| BAF (mSWI/SNF) complex regulates mediolateral cortical patterning in the developing forebrain. | Front Cell Dev Biol | 2022 | 36263009 | PubTator, text mining | PubMed |
| Timing is everything: Transcriptional repression is not the default mode for regulating Hedgehog signaling. | Bioessays | 2022 | 36251875 | PubTator, text mining | PubMed |
| USP7 targets XIAP for cancer progression: Establishment of a p53-independent therapeutic avenue for glioma. | Oncogene | 2022 | 36243803 | PubTator, text mining | PubMed |
| Role of Nanotechnology in Overcoming the Multidrug Resistance in Cancer Therapy: A Review. | Molecules | 2022 | 36235145 | PubTator, text mining | PubMed |
| A Degradation Motif in STAU1 Defines a Novel Family of Proteins Involved in Inflammation. | Int J Mol Sci | 2022 | 36232890 | PubTator, text mining | PubMed |
| High expression of SMARCC1 predicts poor prognosis in gastric cancer patients. | Am J Cancer Res | 2022 | 36225646 | PubTator, text mining | PubMed |
| Molecular characterization of renal cell carcinoma tumors from a phase III anti-angiogenic adjuvant therapy trial. | Nat Commun | 2022 | 36216827 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/6599/papers?page=12